Developer docs
API playgroundTry for free, no card

Search company profiles

Nestlé Health Science

Full company profile

uuid000nqls

Namestring
Nestlé Health Science
Legal namestring
Société des Produits Nestlé S.A.
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Nestlé Health Science is a wholly-owned subsidiary of Nestlé S.A., established in 2011 and headquartered in Vevey, Switzerland, with US consumer operations based in Fremont, Michigan (nestlenutritionstore.com). The company develops and markets science-based nutritional products spanning the full continuum from infant hypoallergenic formulas to geriatric and disease-specific clinical nutrition. Its portfolio of 70+ products is organized under brands including BOOST and Carnation Breakfast Essentials for general supplementation; Peptamen, Nutren, Compleat, Isosource, and Fibersource HN for tube feeding/enteral nutrition; Vivonex and Tolerex for elemental formulas; Alfamino and Extensive HA for hypoallergenic infant formulas; Novasource Renal for dialysis patients; Impact for surgical recovery; Diabetisource AC for diabetes; Beneprotein, Glutasolve, and Arginaid for protein and amino acid supplementation; and ThickenUp Clear for dysphagia. The underlying technology centers on nutritional formulation science — 100% whey peptide-based enteral formulas, free amino acid elemental diets, extensively hydrolyzed hypoallergenic formulas, and disease-specific macronutrient profiles addressing cow's milk protein allergy, diabetes, cancer, renal disease, GI disorders, dysphagia, surgical recovery, and malnutrition.

The business operates through a multi-channel model combining direct-to-consumer e-commerce (nestlenutritionstore.com) with retail pharmacy, healthcare institution, and marketplace distribution across the US, Canada, and India. Revenue is generated through one-time product purchases plus a Subscribe & Save subscription program offering 10% off auto-reorders; consumer supplements range $5–$60 while enteral/tube feeding formulas range $50–$600+. Customers span individual patients across multiple medical conditions, caregivers, and healthcare professionals ordering for hospitals, care facilities, and home healthcare settings. Strategic acquisitions (Atrium Innovations in 2017, Vital Proteins in 2019) and the May 2026 partnership with Dr. Reddy's Laboratories to launch Celevida GLP+ in India demonstrate an active expansion strategy targeting the GLP-1 obesity-drug adjacency and emerging therapeutics markets. As a wholly-owned subsidiary, Nestlé Health Science does not disclose standalone financials, and revenue is reported within Nestlé S.A.'s consolidated results.

Short descriptiontext

Nestlé Health Science, a wholly-owned subsidiary of Nestlé S.A., develops and sells science-based clinical and consumer nutritional products — including oral supplements, tube feeding formulas, and disease-specific nutrition — through D2C e-commerce, pharmacies, and healthcare institutions across the US, Canada, and India.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersFremont, United States
HQ citystring
Fremont
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical nutrition products, enteral feeding formulas, clinical nutritional supplements, pediatric hypoallergenic formulas, therapeutic nutrition solutions
Industry5 codes
1Specialty & Medical Infant Formula (Hypoallergenic, Lactose-Free, Metabolic)
CodeCRADAEABPrimaryYes
2Baby Nutrition for Special Diets (Gluten-Free, Kosher/Halal, Allergen-Controlled)
CodeCRADAEAOPrimaryNo
3Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots)
CodeCRADAGAIPrimaryNo
4Health Food & Supplement Stores
CodeCRAHAEACPrimaryNo
5Sports & Performance Nutrition Foods Manufacturing (Protein Foods, Energy Gels/Bars)
CodeAFAKAJAEPrimaryNo
NAICS code3 codes
  • Food (Health) Supplement Retailers456191
  • Health and Personal Care Retailers456
  • Drugs and Druggists' Sundries Merchant Wholesalers4242
SIC code2 codes
  • Food And Kindred Products2000
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Medical Nutrition
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Consumer Medical Nutrition Products
TypeOne Time License
Description

Sale of nutritional supplements and medical nutrition products directly to consumers through owned e-commerce platform and retail channels. Products include ready-to-drink nutritional shakes, protein powders, tube feeding formulas, and specialized disease-specific nutrition.

nestlenutritionstore.com
2Subscription/Recurring Orders
TypeSubscription Recurring
Description

Auto-reorder subscription model offering 10% discount on regular orders, providing recurring revenue from customers with ongoing nutritional needs

nestlenutritionstore.com
3Healthcare Professional Channel
TypeOne Time License
Description

Products sold through healthcare professionals and providers, including specialized clinical nutrition products for patients in hospitals, care facilities, and home healthcare settings

nestlenutritionstore.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure
Pricing details7 tiers
1Standard Consumer Pricing - Ready-to-Drink Nutritional Supplements
ModelUnit PricingBilling cadencePay-as-you-go
Notes

BOOST products: $10.25-$57.74; Carnation Breakfast Essentials: $5.60-$9.95; BOOST MAX: $11.99

nestlenutritionstore.com
2Protein Supplement Pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Beneprotein Instant Protein Powder: $18.85 for unflavored whey protein supplement

nestlenutritionstore.com
3Specialized Infant/ Pediatric Formula Pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Alfamino Infant/Junior: $48.14; Extensive HA: $44.09

nestlenutritionstore.com
4Enteral/ Tube Feeding Formula Pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Peptamen products: $181-$249; Vivonex products: $316-$605; Nutren products: $54-$61; Compleat products: $95-$229

nestlenutritionstore.com
5Renal and Disease-Specific Nutrition
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Novasource Renal: $104.99; Diabetisource AC: $95.99; Impact Advanced Recovery: $118.44

nestlenutritionstore.com
6Subscription/ Auto-Reorder Discount
ModelSubscriptionBilling cadenceMonthly
Notes

Subscribe & Save: 10% off all auto-reorder subscriptions. Valid for individual purchasers, not healthcare institutions or pharmacy purchases.

nestlenutritionstore.com
7Shipping Thresholds
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Free Ground Shipping on orders $49.95 or more. Flat rate $7.95 for orders under $49.95. Alaska/Hawaii: $29.95 flat rate.

nestlenutritionstore.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 13 records shown
1Alfamino
Description

Hypoallergenic, amino acid-based formula for infants and children with cow's milk protein allergy, multiple food allergies, eosinophilic GI disorders and/or malabsorptive conditions.

nestlenutritionstore.com
+12 more records
Core offering1 text field

Nestlé Health Science develops, manufactures, and sells science-based medical and clinical nutrition products including oral nutritional supplements (BOOST, Carnation Breakfast Essentials), enteral/tube feeding formulas (Peptamen, Nutren, Compleat, Isosource, Fibersource HN), elemental formulas (Vivonex, Tolerex), hypoallergenic infant formulas (Alfamino, Extensive HA), disease-specific nutrition (Diabetisource AC, Novasource Renal, Impact), protein and amino acid supplements (Beneprotein, Glutasolve, Arginaid), and dysphagia management products (ThickenUp Clear). Products are sold direct-to-consumer via owned e-commerce (nestlenutritionstore.com), through pharmacies, retail outlets, e-commerce marketplaces, and to healthcare institutions and professionals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Malnutrition affects up to 50% of older adults and proper nutritional supplementation can help address health outcomes and recovery from illness/hospitalization
+1 more record
Product overview1 text field

Nestlé Health Science operates as a health science company offering a comprehensive portfolio of nutritional products and therapeutic nutrition solutions through its e-commerce platform (nestlenutritionstore.com). The product portfolio includes multiple branded sub-products organized into distinct therapeutic categories: BOOST and Carnation Breakfast Essentials for general nutritional supplementation; Peptamen, Nutren, Compleat, Isosource, and Fibersource HN for tube feeding/enteral nutrition; Vivonex and Tolerex for elemental formulas; Alfamino and Extensive HA for hypoallergenic infant formulas; Nova Source Renal for kidney disease management; Impact for surgical recovery; Diabetisource AC for diabetes management; Beneprotein, Glutasolve, and Arginaid for protein and specialized amino acid supplementation; and ThickenUp Clear for dysphagia management. The company also offers products addressing cancer nutrition, malnutrition, gut health, wound care, and weight management.

Product and service12 records
1BOOST
CategoryOral Nutritional Supplements
Description

Line of nutritional drinks providing tailored nutrition including extra protein, less sugar, more calories, diabetes-friendly nutrition (BOOST Glucose Control), clear liquid nutrition (BOOST Soothe Clear), and everyday supplemental nutrition for adults and pediatric consumers.

2Peptamen
CategoryEnteral / Tube Feeding Nutrition
Description

Nutritionally complete tube-feeding formulas for children and adults offering 100% whey peptide-based options designed to support tolerance and easy digestion in patients with impaired gastrointestinal function.

3Nutren
CategoryEnteral / Tube Feeding Nutrition
Description

Nutritionally complete tube-feeding formulas available with or without fiber offering a wide range of calorie options for adults and pediatric patients requiring enteral nutrition.

4Compleat
CategoryEnteral / Tube Feeding Nutrition
Description

Real food, plant-based and organic tube feeding options for both adult and pediatric patients, made with wholesome ingredients.

5Vivonex
CategoryElemental / Severe GI Nutrition
Description

Nutritionally complete 100% free amino acid formulas for adults and children with severe gastrointestinal (GI) dysfunction, including Vivonex Pediatric Elemental Powder, Vivonex T.E.N., and Vivonex Plus.

6Tolerex
CategoryElemental / Severe GI Nutrition
Description

Elemental formula delivering 100% free amino acids with only two percent of calories from fat for people with severely impaired GI function, used under medical supervision.

7Alfamino
CategoryPediatric Hypoallergenic Formula
Description

Hypoallergenic, amino acid-based formula for infants and children with cow's milk protein allergy, multiple food allergies, eosinophilic GI disorders, and malabsorptive conditions.

8Extensive HA
CategoryPediatric Hypoallergenic Formula
Description

Hypoallergenic extensively hydrolyzed formula for infants from birth to 12 months with cow's milk protein allergy (CMPA); nutritionally complete.

9Nova Source Renal
CategoryDisease-Specific Nutrition
Description

High calorie nutritional drink formulated for people on dialysis, providing protein, vitamins and minerals for those requiring a carefully managed renal diet.

10Diabetisource AC
CategoryDisease-Specific Nutrition
Description

Nutritional product specially formulated for people with diabetes to help manage blood sugar levels as part of a diabetes management plan.

11Impact
CategoryDisease-Specific Nutrition
Description

Formulas supporting the body's immune system and nutritional needs created by major surgery, with specialized nutrients proven in clinical studies to help decrease risk of infection and promote recovery.

12Beneprotein
CategoryProtein and Amino Acid Supplements
Description

Instant protein powder providing six grams of high-quality whey protein per serving that mixes into warm and cold foods and beverages to increase protein content of diet.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-07
Description

Dr. Reddy's Laboratories and Nestlé Health Science jointly launched Celevida GLP+, a specialized nutrition product designed for patients undergoing GLP-1 and GIP-based therapies for type 2 diabetes and obesity management. The product addresses nutritional gaps and supports muscle mass maintenance during such therapies, representing one of the early specialized nutrition offerings in the Indian market around the growing obesity drug market. Available in 350g packs across pharmacies, retail outlets, and leading e-commerce platforms.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Danone's Nutricia division specializes in medical nutrition and is identified alongside NHS as one of the three leading players in therapeutic food delivery for clinical nutrition, with comparable disease-specific formulas and pediatric specialty nutrition products.

TypeDirect peer
Description

Fresenius Kabi is a major global supplier of clinical nutrition products including enteral and parenteral nutrition, competing directly with NHS's Peptamen, Nutren, and Compleat tube feeding brands in hospital and institutional channels.

TypeDirect peer
Description

Baxter offers clinical nutrition products through its hospital and medical products portfolio, competing with NHS in enteral feeding and disease-specific nutrition for institutional customers.

TypeEmerging player
Description

NOW Foods is identified as a major player in the U.S. Dietary Supplements Market, competing in vitamins and nutritional supplements that overlap with NHS's broader wellness and consumer supplement offerings.

TypeEmerging player
Description

Herbalife is identified as a major player in the U.S. Dietary Supplements Market alongside NHS, focusing on meal-replacement shakes and protein supplements — partial overlap with NHS's consumer BOOST and Carnation Breakfast Essentials offerings.

TypeBroad incumbent
Description

Bayer is identified as a major player in the U.S. Dietary Supplements Market. While not specialized in clinical nutrition, Bayer's consumer health division offers nutritional supplements and vitamins that overlap with NHS's broader consumer nutrition portfolio.

TypeBroad incumbent
Description

Amway is identified as a major player in the U.S. Dietary Supplements Market with a broad portfolio of nutritional and wellness products that compete indirectly with NHS's consumer-facing supplement offerings.

TypeDirect peer
Description

Abbott's Nutrition division (Ensure, PediaSure, Similac, Nepro) is the largest direct competitor in clinical and medical nutrition globally, offering overlapping product portfolios across adult nutritional supplements, tube feeding, and infant formulas that directly compete with NHS's BOOST, Peptamen, Vivonex, and Alfamino lines.

TypeDirect peer
Description

Through Mead Johnson Nutrition, Reckitt competes with NHS in infant and child nutrition, including specialty formulas (Enfamil, Nutramigen) for cow's milk protein allergy and metabolic conditions that overlap with NHS's Alfamino and Extensive HA products.

TypeEmerging player
Description

Pharmavite (Nature Made) is identified as a major player in the U.S. Dietary Supplements Market, offering vitamins and supplements that partially overlap with NHS's consumer nutrition and supplement product lines.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nestlé Health Science

Medical Nutritionnestlenutritionstore.com

Nestlé Health Science, a wholly-owned subsidiary of Nestlé S.A., develops and sells science-based clinical and consumer nutritional products — including oral supplements, tube feeding formulas, and disease-specific nutrition — through D2C e-commerce, pharmacies, and healthcare institutions across the US, Canada, and India.

What Nestlé Health Science does

Nestlé Health Science is a wholly-owned subsidiary of Nestlé S.A., established in 2011 and headquartered in Vevey, Switzerland, with US consumer operations based in Fremont, Michigan (nestlenutritionstore.com). The company develops and markets science-based nutritional products spanning the full continuum from infant hypoallergenic formulas to geriatric and disease-specific clinical nutrition. Its portfolio of 70+ products is organized under brands including BOOST and Carnation Breakfast Essentials for general supplementation; Peptamen, Nutren, Compleat, Isosource, and Fibersource HN for tube feeding/enteral nutrition; Vivonex and Tolerex for elemental formulas; Alfamino and Extensive HA for hypoallergenic infant formulas; Novasource Renal for dialysis patients; Impact for surgical recovery; Diabetisource AC for diabetes; Beneprotein, Glutasolve, and Arginaid for protein and amino acid supplementation; and ThickenUp Clear for dysphagia. The underlying technology centers on nutritional formulation science — 100% whey peptide-based enteral formulas, free amino acid elemental diets, extensively hydrolyzed hypoallergenic formulas, and disease-specific macronutrient profiles addressing cow's milk protein allergy, diabetes, cancer, renal disease, GI disorders, dysphagia, surgical recovery, and malnutrition.

The business operates through a multi-channel model combining direct-to-consumer e-commerce (nestlenutritionstore.com) with retail pharmacy, healthcare institution, and marketplace distribution across the US, Canada, and India. Revenue is generated through one-time product purchases plus a Subscribe & Save subscription program offering 10% off auto-reorders; consumer supplements range $5–$60 while enteral/tube feeding formulas range $50–$600+. Customers span individual patients across multiple medical conditions, caregivers, and healthcare professionals ordering for hospitals, care facilities, and home healthcare settings. Strategic acquisitions (Atrium Innovations in 2017, Vital Proteins in 2019) and the May 2026 partnership with Dr. Reddy's Laboratories to launch Celevida GLP+ in India demonstrate an active expansion strategy targeting the GLP-1 obesity-drug adjacency and emerging therapeutics markets. As a wholly-owned subsidiary, Nestlé Health Science does not disclose standalone financials, and revenue is reported within Nestlé S.A.'s consolidated results.

Nestlé Health Science firmographics

Firmographics
Name
Nestlé Health Science
Legal name
Société des Produits Nestlé S.A.
Website
https://nestlenutritionstore.com
Company type
Private
Founded year
2011
Operating status
Operating
Short description
Nestlé Health Science, a wholly-owned subsidiary of Nestlé S.A., develops and sells science-based clinical and consumer nutritional products — including oral supplements, tube feeding formulas, and disease-specific nutrition — through D2C e-commerce, pharmacies, and healthcare institutions across the US, Canada, and India.
Ownership category
akta.pro rank

Nestlé Health Science industry classification

Industry
Product category
Medical Nutrition
NAICS
Food (Health) Supplement Retailers (456191), Health and Personal Care Retailers (456), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
SIC
Food And Kindred Products (2000), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
Specialty & Medical Infant Formula (Hypoallergenic, Lactose-Free, Metabolic) (CRADAEAB)
akta.pro secondary industries
Baby Nutrition for Special Diets (Gluten-Free, Kosher/Halal, Allergen-Controlled) (CRADAEAO), Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots) (CRADAGAI), Health Food & Supplement Stores (CRAHAEAC), Sports & Performance Nutrition Foods Manufacturing (Protein Foods, Energy Gels/Bars) (AFAKAJAE)

Keywords

  • Medical nutrition products
  • Enteral feeding formulas
  • Clinical nutritional supplements
  • Pediatric hypoallergenic formulas
  • Therapeutic nutrition solutions

Where Nestlé Health Science is headquartered

Location

Headquarters

HQ city
Fremont
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Nestlé Health Science business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure

Revenue model

  1. Consumer Medical Nutrition Products: Sale of nutritional supplements and medical nutrition products directly to consumers through owned e-commerce platform and retail channels. Products include ready-to-drink nutritional shakes, protein powders, tube feeding formulas, and specialized disease-specific nutrition.
  2. Subscription/Recurring Orders: Auto-reorder subscription model offering 10% discount on regular orders, providing recurring revenue from customers with ongoing nutritional needs
  3. Healthcare Professional Channel: Products sold through healthcare professionals and providers, including specialized clinical nutrition products for patients in hospitals, care facilities, and home healthcare settings

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard Consumer Pricing - Ready-to-Drink Nutritional Supplements
Unit PricingPay-as-you-goProtein Supplement Pricing
Unit PricingPay-as-you-goSpecialized Infant/ Pediatric Formula Pricing
Unit PricingPay-as-you-goEnteral/ Tube Feeding Formula Pricing
Unit PricingPay-as-you-goRenal and Disease-Specific Nutrition
SubscriptionMonthlySubscription/ Auto-Reorder Discount
Unit PricingPay-as-you-goShipping Thresholds

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Nestlé Health Science product offering

Product offering

Core offering

Nestlé Health Science develops, manufactures, and sells science-based medical and clinical nutrition products including oral nutritional supplements (BOOST, Carnation Breakfast Essentials), enteral/tube feeding formulas (Peptamen, Nutren, Compleat, Isosource, Fibersource HN), elemental formulas (Vivonex, Tolerex), hypoallergenic infant formulas (Alfamino, Extensive HA), disease-specific nutrition (Diabetisource AC, Novasource Renal, Impact), protein and amino acid supplements (Beneprotein, Glutasolve, Arginaid), and dysphagia management products (ThickenUp Clear). Products are sold direct-to-consumer via owned e-commerce (nestlenutritionstore.com), through pharmacies, retail outlets, e-commerce marketplaces, and to healthcare institutions and professionals.

Product overview

Nestlé Health Science operates as a health science company offering a comprehensive portfolio of nutritional products and therapeutic nutrition solutions through its e-commerce platform (nestlenutritionstore.com). The product portfolio includes multiple branded sub-products organized into distinct therapeutic categories: BOOST and Carnation Breakfast Essentials for general nutritional supplementation; Peptamen, Nutren, Compleat, Isosource, and Fibersource HN for tube feeding/enteral nutrition; Vivonex and Tolerex for elemental formulas; Alfamino and Extensive HA for hypoallergenic infant formulas; Nova Source Renal for kidney disease management; Impact for surgical recovery; Diabetisource AC for diabetes management; Beneprotein, Glutasolve, and Arginaid for protein and specialized amino acid supplementation; and ThickenUp Clear for dysphagia management. The company also offers products addressing cancer nutrition, malnutrition, gut health, wound care, and weight management.

Differentiator

Problem solved

Functional benefit

Brands

  • Alfamino: Hypoallergenic, amino acid-based formula for infants and children with cow's milk protein allergy, multiple food allergies, eosinophilic GI disorders and/or malabsorptive conditions.
  • Beneprotein
  • BOOST
  • Carnation Breakfast Essentials
  • Compleat
  • Extensive HA
  • Impact
  • Nova Source (Novasource)
  • Nutren
  • Peptamen
  • ThickenUp Clear
  • Tolerex
  • Vivonex

Products and services

  • BOOST Line of nutritional drinks providing tailored nutrition including extra protein, less sugar, more calories, diabetes-friendly nutrition (BOOST Glucose Control), clear liquid nutrition (BOOST Soothe Clear), and everyday supplemental nutrition for adults and pediatric consumers.
  • Peptamen Nutritionally complete tube-feeding formulas for children and adults offering 100% whey peptide-based options designed to support tolerance and easy digestion in patients with impaired gastrointestinal function.
  • Nutren Nutritionally complete tube-feeding formulas available with or without fiber offering a wide range of calorie options for adults and pediatric patients requiring enteral nutrition.
  • Compleat Real food, plant-based and organic tube feeding options for both adult and pediatric patients, made with wholesome ingredients.
  • Vivonex Nutritionally complete 100% free amino acid formulas for adults and children with severe gastrointestinal (GI) dysfunction, including Vivonex Pediatric Elemental Powder, Vivonex T.E.N., and Vivonex Plus.
  • Tolerex Elemental formula delivering 100% free amino acids with only two percent of calories from fat for people with severely impaired GI function, used under medical supervision.
  • Alfamino Hypoallergenic, amino acid-based formula for infants and children with cow's milk protein allergy, multiple food allergies, eosinophilic GI disorders, and malabsorptive conditions.
  • Extensive HA Hypoallergenic extensively hydrolyzed formula for infants from birth to 12 months with cow's milk protein allergy (CMPA); nutritionally complete.
  • Nova Source Renal High calorie nutritional drink formulated for people on dialysis, providing protein, vitamins and minerals for those requiring a carefully managed renal diet.
  • Diabetisource AC Nutritional product specially formulated for people with diabetes to help manage blood sugar levels as part of a diabetes management plan.
  • Impact Formulas supporting the body's immune system and nutritional needs created by major surgery, with specialized nutrients proven in clinical studies to help decrease risk of infection and promote recovery.
  • Beneprotein Instant protein powder providing six grams of high-quality whey protein per serving that mixes into warm and cold foods and beverages to increase protein content of diet.

Quantifiable outcome

  • Malnutrition affects up to 50% of older adults and proper nutritional supplementation can help address health outcomes and recovery from illness/hospitalization
  • +1 more outcomes

Companies that use Nestlé Health Science

Customer profile

Named customers8 records

Segments6 records

Ideal customer profiles3 records

Nestlé Health Science technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Nestlé Health Science partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Dr. Reddy's LaboratoriescoreStrategic or Co-development Partner · 7 May 2026Dr. Reddy's Laboratories and Nestlé Health Science jointly launched Celevida GLP+, a specialized nutrition product designed for patients undergoing GLP-1 and GIP-based therapies for type 2 diabetes and obesity management. The product addresses nutritional gaps and supports muscle mass maintenance during such therapies, representing one of the early specialized nutrition offerings in the Indian market around the growing obesity drug market. Available in 350g packs across pharmacies, retail outlets, and leading e-commerce platforms.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Nestlé Health Science competitors and assessment

Company assessment

Direct peers

  • Danone (Nutricia): Danone's Nutricia division specializes in medical nutrition and is identified alongside NHS as one of the three leading players in therapeutic food delivery for clinical nutrition, with comparable disease-specific formulas and pediatric specialty nutrition products.
  • Fresenius Kabi: Fresenius Kabi is a major global supplier of clinical nutrition products including enteral and parenteral nutrition, competing directly with NHS's Peptamen, Nutren, and Compleat tube feeding brands in hospital and institutional channels.
  • Baxter International: Baxter offers clinical nutrition products through its hospital and medical products portfolio, competing with NHS in enteral feeding and disease-specific nutrition for institutional customers.
  • Abbott (Abbott Nutrition): Abbott's Nutrition division (Ensure, PediaSure, Similac, Nepro) is the largest direct competitor in clinical and medical nutrition globally, offering overlapping product portfolios across adult nutritional supplements, tube feeding, and infant formulas that directly compete with NHS's BOOST, Peptamen, Vivonex, and Alfamino lines.
  • Reckitt Benckiser (Mead Johnson): Through Mead Johnson Nutrition, Reckitt competes with NHS in infant and child nutrition, including specialty formulas (Enfamil, Nutramigen) for cow's milk protein allergy and metabolic conditions that overlap with NHS's Alfamino and Extensive HA products.

Emerging players

  • NOW Foods: NOW Foods is identified as a major player in the U.S. Dietary Supplements Market, competing in vitamins and nutritional supplements that overlap with NHS's broader wellness and consumer supplement offerings.
  • Herbalife: Herbalife is identified as a major player in the U.S. Dietary Supplements Market alongside NHS, focusing on meal-replacement shakes and protein supplements — partial overlap with NHS's consumer BOOST and Carnation Breakfast Essentials offerings.
  • Pharmavite: Pharmavite (Nature Made) is identified as a major player in the U.S. Dietary Supplements Market, offering vitamins and supplements that partially overlap with NHS's consumer nutrition and supplement product lines.

Broad incumbents

  • Bayer AG: Bayer is identified as a major player in the U.S. Dietary Supplements Market. While not specialized in clinical nutrition, Bayer's consumer health division offers nutritional supplements and vitamins that overlap with NHS's broader consumer nutrition portfolio.
  • Amway: Amway is identified as a major player in the U.S. Dietary Supplements Market with a broad portfolio of nutritional and wellness products that compete indirectly with NHS's consumer-facing supplement offerings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Nestlé Health Science social profiles

Digital presence

Nestlé Health Science financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nestlé Health Science leadership team

Management profile

Number of profiles

Nestlé Health Science subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Nestlé Health Science funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nestlé Health Science M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nestlé Health Science

What does Nestlé Health Science do?

Nestlé Health Science develops, manufactures, and sells science-based medical and clinical nutrition products including oral nutritional supplements (BOOST, Carnation Breakfast Essentials), enteral/tube feeding formulas (Peptamen, Nutren, Compleat, Isosource, Fibersource HN), elemental formulas (Vivonex, Tolerex), hypoallergenic infant formulas (Alfamino, Extensive HA), disease-specific nutrition (Diabetisource AC, Novasource Renal, Impact), protein and amino acid supplements (Beneprotein, Glutasolve, Arginaid), and dysphagia management products (ThickenUp Clear). Products are sold direct-to-consumer via owned e-commerce (nestlenutritionstore.com), through pharmacies, retail outlets, e-commerce marketplaces, and to healthcare institutions and professionals.

Is Nestlé Health Science a public or private company?

Nestlé Health Science is a private company. It is classified as corporate owned and is currently operating.

When was Nestlé Health Science founded?

Nestlé Health Science was founded in 2011.

Where is Nestlé Health Science based?

Nestlé Health Science is headquartered in Fremont, United States, in the North America region.

How does Nestlé Health Science make money?

Three revenue lines are on record. Consumer Medical Nutrition Products are the primary driver. The others are subscription/Recurring Orders and healthcare Professional Channel.

Who are Nestlé Health Science's main competitors?

Direct peers on record are Danone (Nutricia), Fresenius Kabi, Baxter International, Abbott (Abbott Nutrition) and Reckitt Benckiser (Mead Johnson). Emerging players are NOW Foods, Herbalife and Pharmavite. Broad incumbents are Bayer AG and Amway.

Does Nestlé Health Science have an API?

No public API is recorded for Nestlé Health Science.

What industry is Nestlé Health Science in?

Nestlé Health Science's product category is Medical Nutrition. Its primary akta.pro industry code is CRADAEAB, Specialty & Medical Infant Formula (Hypoallergenic, Lactose-Free, Metabolic), with a secondary code of CRADAEAO, Baby Nutrition for Special Diets (Gluten-Free, Kosher/Halal, Allergen-Controlled). Its NAICS code is 456191 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SnackandbakeryOcean Spray recruits Abigail Buckwater as president, CEO | Snack Food & Wholesale BakeryOcean Spray Cranberries, Inc. announced the appointment of Abigail Buckwalter as president and chief executive officer. Buckwalter brings 20 years of global leadership experience, having most recently served as CEO of Nestlé Health Science U.S., where she led an organization of more than 6,000 people and managed a multi-billion-dollar portfolio of global consumer and healthcare brands. The company's chairman praised her transformational leadership and people-first approach as key attributes to guide Ocean Spray into its second century of business.HrtodayOcean Spray Names Abigail Buckwalter President and Chief Executive OfficerOcean Spray Cranberries, Inc. announced the appointment of Abigail Buckwalter as President and Chief Executive Officer, effective June 2026. Buckwalter joins from Nestlé Health Science U.S., where she served as CEO for three years managing a multi-billion-dollar portfolio of global consumer and healthcare brands with over 6,000 employees. The cooperative, owned by roughly 700 family farmers in the United States, Canada, and Chile, positioned her appointment as key to leading the company through evolving consumer behavior and buying habits into its second century of business.PR NewswireOcean Spray Names Abigail Buckwalter President and Chief Executive OfficerOcean Spray Cranberries, Inc. announced the appointment of Abigail Buckwalter as President and Chief Executive Officer, effective June 22, 2026. Buckwalter joins from Nestlé Health Science U.S., where she served as CEO for three years leading more than 6,000 employees and managing a multi-billion-dollar portfolio of global consumer and healthcare brands. The appointment is described as part of the cooperative's effort to navigate a dynamic shift in consumer behavior and buying habits as it approaches its second century of operation.MarketsandMarketsProbiotic Supplement Market Report 2026-2031 [400 Pages & 250 Tables]MarketsandMarkets published a comprehensive market research report projecting the global probiotic supplements market to reach USD 16.69 billion by 2031 from USD 10.60 billion in 2026, growing at a CAGR of 9.5% during the forecast period. Key recent developments include Yakult Europe B.V.'s merger with Yakult Oesterreich GmbH in October 2025 to streamline European operations, Nestlé Health Science's acquisition of Vital Proteins in February 2022 to expand its gut health portfolio, and Symrise's launch of SymReboot OC in July 2021 targeting oral health applications. The report identifies 15 key market players including Nestlé S.A., Yakult Honsha, Symrise AG, Kerry Group, and Herbalife, while also profiling emerging startups such as Seed Health, Pendulum Therapeutics, and Flore Inc.Market Data ForecastU.S Dietary Supplements Market Size, Share & Growth, 2034This article is a market research report providing comprehensive analysis of the U.S. dietary supplements market, which was valued at USD 74.18 billion in 2025 and is projected to reach USD 137.09 billion by 2034, growing at a CAGR of 7.76%. The report details market drivers including rising consumer awareness of preventive healthcare, increasing chronic disease prevalence, and growing demand for personalized nutrition solutions, as well as restraints such as regulatory ambiguity and product quality concerns. The competitive landscape features major players including Bayer AG, Sanofi SA, Nestlé Health Science, Glanbia plc, Amway, Herbalife, NOW Foods, Pharmavite, and Unilever.Business TodayDr. Reddy’s, Nestlé Health Science launch nutrition product for patients on obesity drugsDr. Reddy's Laboratories and Nestlé Health Science launched Celevida GLP+, a specialized nutrition product for patients undergoing GLP-1 and GIP-based therapies for diabetes and obesity. The product addresses concerns around muscle loss and nutritional deficiencies, as studies indicate 25-40% of weight loss from these therapies may come from lean body mass. This marks one of the early attempts in India to build specialized nutrition offerings around the fast-growing obesity drug market.BusinessLineDr. Reddy’s & Nestle Health Science launches Celevida GLP PlusDr. Reddy's and Nestlé Health Science launched Celevida GLP Plus, a specialized nutritional product, in the Indian domestic market on May 7, 2026. The product is designed to support nutrition intake and muscle mass maintenance for patients undergoing GLP-1/GIP therapy for type 2 diabetes and obesity management. Celevida GLP+ is available in 350g packs across pharmacies, retail outlets, and leading e-commerce platforms.BusinessLineDr. Reddy’s & Nestle Health Science launches Celevida GLP PlusDr. Reddy's Laboratories and Nestlé Health Science have launched Celevida GLP Plus, a specialized nutritional product for patients undergoing GLP-1/GIP therapy for type 2 diabetes and obesity management, in the Indian domestic market. The product addresses nutrition gaps and supports muscle mass maintenance during such therapies, responding to what the companies describe as a clear unmet need. Celevida GLP+ is available in 350g packs across pharmacies, retail outlets, and leading e-commerce platforms.Market Research & Business IntelligenceTherapeutic Food Delivery for Clinical Nutrition Market Size, Share & Forecast to 2036The therapeutic food delivery for clinical nutrition market was valued at USD 8.7 billion in 2025 and is projected to reach USD 18.0 billion by 2036, growing at a 6.8% CAGR, as payers integrate prescribed meal regimens into post-discharge pathways and health systems shift recovery and chronic disease management into home settings. Hospital readmission penalties are driving discharge planners to secure reliable home-based feeding logistics, with homecare providers leading the distribution channel at 46.7% revenue share and post-acute home settings accounting for 48.9% of care settings. China leads national growth at 8.1% CAGR followed by India at 7.8%, while established players including Abbott, Nestlé Health Science, and Danone Nutricia maintain competitive advantages through integrated distribution networks and reimbursement navigation capabilities.Coherent Market InsightsClinical Nutrition Market Size, Share & Analysis, 2026-2033The global clinical nutrition market is projected to grow from USD 13.97 billion in 2026 to USD 21.28 billion by 2033, representing a compound annual growth rate of 6.2%, driven by rising chronic disease prevalence, aging populations, and increasing healthcare awareness. North America is expected to lead the market with a 46.7% share in 2026, supported by robust healthcare infrastructure and favorable reimbursement policies. Recent developments include new product launches by Abbott, Nestlé Health Science, and Danone, expanded FDA clearances for pediatric nutritional products, and stricter labeling regulations from the EMA and India's FSSAI, reflecting ongoing innovation and regulatory evolution across the sector.